Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Phoenix-Micron, Inc. launches the next generation of its MICRON in vivo ophthalmic imaging platform for small animal research


Designed to enhance efficiency and repeatability, the MICRON 5 platform boasts a range of core, patent-pending features, including interchangeable imaging sensors and software-controlled camera operation, expanded excitation and barrier filter capabilities, and new depth of field adjustments.

Phoenix-Micron, Inc. today announced the launch of the all-new Phoenix MICRON® 5 imaging system, the latest breakthrough in small animal ophthalmic imaging technology. With over 450 published studies utilizing MICRON imaging systems, the MICRON platform has provided researchers with precision tools for imaging and data capture for over 14 years. The patented MICRON 5 is the next generation of the Company’s industry-leading platform to power eye and eye-brain research. Orders are being accepted for MICRON 5 systems now, and first deliveries are expected this summer.

Designed to enhance efficiency and repeatability, the MICRON 5 platform boasts a range of core, patent-pending features, including interchangeable imaging sensors and software-controlled camera operation, expanded excitation and barrier filter capabilities, and new depth of field adjustments. These new capabilities provide endless opportunities for researchers to fine-tune their in vivo imaging and capture more precise data more easily.

Understanding the importance of protecting the investment MICRON customers make in capital equipment, the MICRON 5 camera is compatible with the imaging modalities from the prior MICRON IV generation. This allows for a smooth upgrade to the newest technology platform with the lowest total-cost-of-ownership.

“We are thrilled to introduce the all-new Phoenix MICRON 5 platform to the research community,” said Scott Carr, CEO Of Phoenix-Micron, Inc. “Our team has spent the last several years developing the software and hardware that powers the MICRON 5 platform to bring researchers the latest imaging and data capture capabilities. We are in awe of the discoveries in science and medicine that our research customers develop, and we are committed to continuing our tradition of innovation in order to meet our customers’ needs with the MICRON 5.”

The MICRON 5 introduces powerful capabilities to enhance the quality of imaging and data capture in experiments with small animals:

  • Interchangeable camera sensors offer the option to fine-tune fidelity, quantum efficiency, and spatial precision to more precisely image specific cellular and molecular features
  • Focus, illumination, and filter selection are now under software control, speeding the imaging workflow and increasing the metadata that the MICRON 5 camera can capture about each image, enhancing analysis and experiment repeatability
  • Excitation and barrier filters have been completely redesigned to radically improve usability, automatically detect installed filters, and make it easier to use a wide range of wavelengths to tailor illumination and sampled light to your requirements
  • A new adjustable aperture has been added to offer control over depth of field, enabling better imaging of dimensional structures including tumors, cysts, and properties of the vitreous. In addition, this improves the ability to image highly reflective retina, such as those present in albino rodents.
  • The MICRON 5 camera is fully compatible with the new MICRON LT2 lens technology, shortening the time required to quickly change imaging modalities with precision alignment
  • The MICRON 5 camera is fully compatible with the newly released MICRON Software Suite, which delivers advanced image and data management capabilities to help efficiently power your research and data analysis

For more information on the Phoenix MICRON 5, please click here.

About Phoenix-Micron, Inc.: Phoenix-Micron, Inc.is a global leader in in vivo ophthalmic imaging of laboratory animals. MICRON systems are optimized for eye and eye-brain research. The patented MICRON platform delivers seven essential imaging modalities in a compact footprint, backed by world-class service, that’s ideal for the exacting data capture and physical space requirements of small animal research labs. Each piece of the MICRON system is designed to ease the researcher’s workflow and capture and manage the high-resolution ophthalmic images and associated data that helps bring ophthalmic research to life. Since its initial launch in 2007, MICRON camera systems have been installed in hundreds of ophthalmic and neurologic research labs in more than 25 countries. Found in 11 of the world’s top 12 research institutes, MICRON systems have been used by authors of more than 450 published studies. For more information about Phoenix-Micron, Inc. and the Phoenix MICRON® in-vivo imaging system, contact Jen King, jen.king@phoenixmicron.com.

Share article on social media or email:

Phoenix-Micron, Inc. Announces New, Comprehensive Imaging Software and Redesigned Lens Technology for the Phoenix MICRON® Imaging Platform


Our two newest innovations – MICRON Software Suite and the new MICRON LT2 lens technology – streamline the ophthalmic imaging workflow and introduce all new data management capabilities to reduce the time required to capture precision images and data for in vivo small animal research.

Phoenix-Micron, Inc., a leader in ophthalmic imaging technology, today announced the release of the new MICRON® Software Suite and the MICRON LT2 lens technology. The new MICRON Software Suite streamlines the ophthalmic imaging workflow and captures and manages even more valuable research data about small subject animals. Also announced today, the patent-pending, MICRON LT2 lens technology represents a complete redesign of MICRON objective lenses that makes precision optical alignment easier and more repeatable. Both innovations are compatible with the MICRON IV and all-new MICRON 5 imaging platforms.

MICRON Software Suite delivers a user experience designed for researchers imaging the eyes of small animals. Animal subject data management, multi-modality image capture, and search and export are all integrated into a single application. The new software platform seamlessly integrates into the eye and eye-brain research workflow. And, with the ability to record and export subject and experiment-specific data, MICRON Software Suite facilitates in-depth analysis of the eyes of small animals.

“As a company, we are deeply committed to empowering scientific researchers with cutting-edge tools that help our customers achieve breakthrough discoveries,” said Scott Carr, Phoenix-Micron, Inc CEO. “And part of our innovation focus is to reduce the time and effort required to capture data and images from experiments, while also improving experiment repeatability. Our two newest innovations – MICRON Software Suite and the new MICRON LT2 lens technology – streamline the ophthalmic imaging workflow and introduce all new data management capabilities to reduce the time required to capture precision images and data for in vivo small animal research.”

MICRON Software Suite offers multiple features that simplify the imaging process and integrate their Phoenix MICRON imaging data all in one place and with an intuitive user experience:

1. Unified Application – Capture fundus images, OCT scans, and slit lamp images; launch OCT segmentation tools; aim and document laser burns; and capture ERG reference images and launch ERG data capture all from a single application.

2. Data Management – All new M-Tags help you build data capture directly into your imaging workflow. Annotate subjects, imaging sessions, and images with keywords and/or keyword/value pairs to improve searchability and greatly enhance the analytic value of images captured with MICRON systems.

a. Make use of automatically generated M-Tags that add data depth to your images, including key attributes such as selected filter, illumination power, focus settings, and more.

b. Create M-Tags on the fly, without the need to predefine a database schema or design forms. Create M-Tag annotations while imaging to meet the requirements of your lab, study, and experiments to capture data where and when you need it, reducing the need for external spreadsheets and papers.

3. Image Management – Easily search for, browse, export, and manage images across modalities from one application, dramatically shortening the time it takes to find and organize images and data for analysis and publication.

4. MICRON System Share – Share a single MICRON imaging system with multiple labs while controlling which users can access data from each lab.

5. OCT Launch – Launch OCT segmentation tools directly from the new image review page, simplifying the OCT imaging workflow

The MICRON LT2 lens technology increases reliability, serviceability, and ease-of-use for MICRON IV and MICRON 5 systems, and radically reduces the time required for multi-modality imaging, including fundus, OCT, laser, and focal ERG products.

1. The new MICRON 5 and MICRON IV objective lens sets with MICRON LT2 lens technology introduces new calibration capabilities that allow the final alignment of objective lens components to be performed both at the factory and at the customer site.

2. With this feature, customers can add new imaging modalities to their MICRON system without requiring the system be returned to the factory for calibration. And the time to repair lens sets has been greatly reduced in the unlikely and unfortunate event that a removable objective lens set is damaged.

3. When used with the all-new MICRON 5, the new MICRON LT2 lens technology replaces the screw-on attachment mechanism found in prior MICRON generations with a new, self-seating design. Objective lenses slide on to the camera and magnetically snap into place, making it even easier to switch from one imaging modality to another with precision alignment. This also radically reduces the time needed to switch between imaging modalities, which is ideal for workflows such as verifying a laser burn with OCT.

For more information on the Phoenix MICRON imaging platform please click here.

About Phoenix-Micron, Inc.: Phoenix-Micron, Inc.is a global leader in in vivo ophthalmic imaging of laboratory animals. MICRON systems are optimized for eye and eye-brain research. The patented MICRON platform delivers seven essential imaging modalities in a compact footprint, backed by world-class service, that’s ideal for the exacting data capture and physical space requirements of small animal research labs. Each piece of the MICRON system is designed to ease the researcher’s workflow and capture and manage the high-resolution ophthalmic images and associated data that helps bring ophthalmic research to life. Since its initial launch in 2007, MICRON camera systems have been installed in hundreds of ophthalmic and neurologic research labs in more than 25 countries. Found in 11 of the world’s top 12 research institutes, MICRON systems have been used by authors of more than 450 published studies.

For more information about Phoenix-Micron, Inc. and the Phoenix MICRON® in-vivo imaging system, contact Jen King, jen.king@phoenixmicron.com.

Share article on social media or email:

Digital Lab Consulting Achieves King’s Award for Enterprise


“We’re thrilled to have been recognised with this award. It’s a reflection of the fantastic work done by the DLC team and the strong business partnerships we’ve established with leading R&D organisations around the globe,” said Dr. Eliot Randle, Co-Founder of Digital Lab Consulting.

Digital Lab Consulting (DLC) is one of only 148 organisations in the United Kingdom to be recognised in this year’s King’s Award for Enterprise. The awards celebrate the success of exciting and innovative businesses which are leading the way with pioneering products or services, demonstrating sustained, outstanding overseas growth, delivering impressive social mobility programmes, or showing their commitment to excellent sustainable development practices.

The accolade was given in recognition of DLC’s sustained, outstanding growth in earnings outside the UK, with overseas sales up by more than fivefold in the four years to 2022. Founded in 2018, the company has grown rapidly from a two-person partnership to an established strategic consulting company with 16 UK-based employees.

DLC, which joined ProPharma in January 2023, provides R&D technology services to include digital transformation, strategic roadmap development, system selection and high-level business analysis consulting. DLC has built a reputation as a strategic partner throughout the life sciences industry, providing business and technical consulting expertise and experience to enable organisations of all sizes to transform their business through better use of data and technology.

The King’s Awards for Enterprise was previously known as The Queen’s Awards for Enterprise, and the new name reflects His Majesty The King’s desire to continue the legacy of HM Queen Elizabeth II’s by recognising outstanding UK businesses. The Award programme, now in its 57th year, is the most prestigious business award in the country.

Dr. Eliot Randle, Co-Founder of Digital Lab Consulting, said: “We’re thrilled to have been recognised with this award. It’s a reflection of the fantastic work done by the DLC team and the strong business partnerships we’ve established with leading R&D organisations around the globe.”

Roger Shaw, Co-Founder of Digital Lab Consulting, said: “We’re absolutely delighted that our team has been recognised for the transformative impact to our clients’ digital journeys.”

Applications for King’s Awards for Enterprise 2024 open on His Majesty The King’s Coronation, 6th May 2023 For more information, visit https://www.gov.uk/kings-awards-for-enterprise.

About Digital Lab Consulting

Since 2018, Digital Lab Consulting (DLC) – a ProPharma company – has been a strategic partner, providing deep industry and digital transformation expertise to enable organisations of all sizes to transform their business through better use of data and technology. With global reach and scale, underpinned by deep market knowledge of established, upcoming, and disruptive technologies, trends, and industry standards, DLC’s expertise covers a wide range of skill sets and capabilities across the pharma value chain. As a collaborative and flexible partner, DLC consistently endeavours to optimise processes and share innovations with its clients that maximise value, drive efficiency, and reduce costs, while maintaining quality. For further information about Digital Lab Consulting, please visit: https://www.dlc.io.

About the King’s Awards

The King’s Awards for Enterprise are the most prestigious business awards in the UK. The awards were first established in 1965 and since then over 7,000 companies have achieved a King’s Award. 2023 marks the first year of The King’s Awards for Enterprise, reflecting His Majesty The King’s desire to continue the legacy of HM Queen Elizabeth II’s by recognising outstanding UK businesses.

The awards celebrate the success of exciting and innovative businesses which are leading the way with pioneering products or services, delivering impressive social mobility programmes, or showing their commitment to excellent sustainable development practices.

This year 148 businesses have been recognised for their contribution to International Trade, Innovation, Sustainable Development and Promoting Opportunity (through Social Mobility). A total of 149 Awards are made with one company being recognised with two Awards.

###

Media Contact:

Jason Wakeford

Clarity for Digital Lab Consulting

propharmagroup@clarity.global

Share article on social media or email:

Green Blazer recognized as #683 on INC 5000 Business List for 2022


Inc 5000 graphic representing Green Blazer as the 683rd fastest growing company in the United State in 2022

Green Blazer recognized as #683 on INC 5000 List

“As we continue to grow out our product line for our customers on digital platforms, it’s a natural extension for us to start offering wholesale product lines to businesses as well,” noted Jake Peterson.

Green Blazer, a Las Vegas-based online retailer of pre-rolled cones and smoking accessories, has been recognized for its impressive growth on the 2022 Inc 5000 fastest growing companies list, coming in at #683. Founded in 2018, Green Blazer is dedicated to curating the finest brands and products in the ancillary smoking industry and providing consumers with a one-stop shop for all their smoking needs.

“We are thrilled to be recognized as one of the fastest growing companies in America,” said Jake Peterson, the founder and CEO of Green Blazer. “We’ve spent years developing amazing partners in our industry and our proud to usher in the expansion of unique products and brands to our market.”

Green Blazer’s unique partnership with RAW, one of the most recognizable brands in the industry, offers consumers the chance to purchase DIY kits of RAW Cones and accessories comprised of RAWthentic products. Their extensive product line can be found on their website at greenblazer.com and on their Amazon storefront, where they are a top .1% seller on the platform with over 55,000 5-star reviews.

With a commitment to curating the most desired products and brands, and a 100% Satisfaction Guarantee, Green Blazer is planning on pushing further into the B2B industry to work with more cultivators, retailers, and preroll production companies.

“As we continue to grow out our product line for our customers on digital platforms, it’s a natural extension for us to start offering wholesale product lines to businesses as well,” noted Jake Peterson.

For more information on Green Blazer and their products, please visit their website at greenblazer.com.

Contact: Hannah Heathers

Green Blazer – http://www.greenblazer.com

Phone: 702-491-7738

Email: hannah@thegreenblazer.com

Share article on social media or email:

Evertone Skin Launches Body Care Line Targeting Cellulite and Stretch Marks


News Image

Together we were able to create a line of products that strives to give women solutions to their skincare problems while also encouraging them to love their bodies.

Evertone Skin, a leading direct-to-consumer body care line targeting cellulite and stretch marks, is launching their brand of body care products for consumers to purchase online. The brand was founded with the mission to give women solutions to their body care concerns with products formulated for women, by women to address common skin issues that over 90% of women face every day.

All of Evertone Skin’s products are made in the USA with clean, effective ingredients and have been clinically tested and proven to reduce the appearance of cellulite and stretch marks by breaking down the fat cells underneath the skin, exfoliating the top layers of stretch marks to reveal a smooth surface and reintroducing the elasticity back into the skin.

Evertone Skin’s featured body care products include:

  • Bounce Back – Anti-Cellulite Bundle works together perfectly to target any areas of concern. The bundle includes the Body Exfoliator, Body Firmer, Body Shaper, and a Gua Sha Tool that is formulated to promote cell turnover, exfoliate impurities, and increase blood flow. 
  • Anti-Stretch Mark Body Care Routine – Final Stretch Bundle is the perfect routine to help minimize the appearance of stretch marks. This bundle consists of the Body Detoxifier, Body Refresher, Body Smoother, and a Gua Sha Tool to exfoliate, stimulate skin renewal, and brighten, while keeping your skin supple and hydrated. 
  • Red Light Therapy Wand helps fade blemishes and dark spots, smooths fine lines, decreases puffiness, and gives the skin a youthful glow.
  • Microcurrent Facial Toning Device uses a low-grade electrical current to lift, tighten, tone, and contour the facial muscles while reducing the appearance of fine lines and wrinkles.

“Having worked in the skincare industry for the last two decades, I noticed there were so many innovative facial skincare brands but none of them targeted body skin issues,” said Alex Franklyn, CEO of Evertone Skin. “I was on a mission to develop a body care brand to fill in the gap of the industry. Eventually I connected with Polett Menaskan, our now Head of Product Development, who had the vision, connections, and top of the line chemists to help make our brand come to life. Together we were able to create a line of products that strives to give women solutions to their skincare problems while also encouraging them to love their bodies.”

To learn more about Evertone Skin’s products, please visit https://evertoneskin.com.

About Evertone Skin

Evertone Skin is a clinically tested, dermatologist approved, body skincare line that focuses on targeting areas of concern for women. Their products have been professionally formulated for women by women using clean and effective ingredients and have been clinically tested and proven to reduce the appearance of cellulite and stretch marks. Most products are vegan, pregnancy safe, and breastfeeding safe.

Share article on social media or email:

Morehouse School of Medicine’s “Danforth Dialogues” Features Spelman College President Dr. Helene Gayle


Morehouse School of Medicine (MSM) today published the latest edition of its “Danforth Dialogues” podcast, featuring a conversation between MSM President and CEO Dr. Valerie Montgomery Rice and Spelman College President Dr. Helene Gayle, a renowned health care leader and humanitarian.

Dr. Gayle, one of the country’s foremost medical researchers during her 20-year career at the Centers for Disease Control and Prevention, helped to formulate global health initiatives at the Bill and Melinda Gates Foundation before serving as President and CEO of CARE USA for nearly a decade. She became the 11th president of Spelman last year after heading the Chicago Community Trust.

“Dr. Gayle is a living testament to how one can leverage their foundational talents and experiences to lead a diverse set of organizations and have a significant impact on the human experience, particularly for disadvantaged communities around the world,” said Dr. Montgomery Rice. “She brings a unique insight into leadership and service that few of us can match.”

A graduate of the University of Pennsylvania Medical School, Dr. Gayle discussed how she moved from being a CDC researcher to leading the world’s largest humanitarian organizations, and the challenges she faced as she shifted into those new roles.

“Making the transition from being an individual contributor to being a leader of people is often challenging,” Dr. Gayle said. “We are often put in leadership positions because we did well as individual contributors…(but) if you are not empowering others to do their job, you will end up doing everybody’s job and that is not a good role for a leader.”

Dr. Gayle also commented on how she views Spelman as she nears the end of her first year as president of the school, calling it a “Wakanda for Black women,” noting, “It’s hard to describe, you have to experience it. To be in a place… where everyone is aspiring for your success. There is a spirit that we are all here for each other.”

Launched in 2022, Danforth Dialogues focuses on leadership lessons from the frontlines of the COVID-19 pandemic and their broader implications for society. Named after the historic Danforth Chapel on the Morehouse College campus, the podcast series features a cross-section of guests and topics.

To hear this edition of the podcast, click here. For more information about the Danforth Dialogues leadership series, click here.

To listen and subscribe to the Danforth Dialogues podcast, click here.

For more information about Morehouse School of Medicine, please visit MSM.edu.

###

About Morehouse School of Medicine

Founded in 1975, Morehouse School of Medicine (MSM) is among the nation’s leading educators of primary care physicians, biomedical scientists, and public health professionals. An independent and private historically-Black medical school, MSM was recognized by the Annals of Internal Medicine as the nation’s number one medical school in fulfilling a social mission—the creation and advancement of health equity. Morehouse School of Medicine’s faculty and alumni are noted for excellence in teaching, research, and public policy, as well as exceptional patient care. MSM is accredited by the Commission on Colleges of the Southern Association of Colleges and Schools to award doctoral and master’s degrees. To learn more about programs and donate today, please visit http://www.msm.edu or call 404-752-1500.

Contact:

Jamille Bradfield

Morehouse School of Medicine

mailto:jbradfield@msm.edu [jbradfield@msm.edu __title__ null]

Share article on social media or email:

UnitedRx Celebrates Breakthrough Development in Affordability and Access to Essential Diabetes Medication


UnitedRx

“Insulin pricing reductions will benefit both patients and healthcare providers. Lower insulin prices will enable more patients to afford the treatment they need to manage their condition and maintain their health,” says UnitedRx CEO Chuck Benain.

UnitedRx, the Midwest’s largest full-service, independent long-term care pharmacy, is proud to announce its support for the recent drop in insulin prices throughout the United States. Three major insulin manufacturers – Eli Lilly, Novo Nordisk, and Sanofi – are reducing their product prices, a monumental win for patients, healthcare professionals, and the long-term care industry. Eli Lilly is at the forefront of this change, while Novo Nordisk and Sanofi plan to introduce more affordable options later this year.

“Insulin pricing reductions will benefit both patients and healthcare providers. Lower insulin prices will enable more patients to afford the treatment they need to manage their condition and maintain their health,” says UnitedRx CEO Chuck Benain. “This initiative will transform how diabetic patients are cared for by making it easier for more people to obtain life-saving drugs and relieving the financial pressure on patients and their families.”

After the Inflation Reduction Act was passed, the monthly out-of-pocket price of insulin for Medicare seniors was fixed at $35. Following pressure from President Joe Biden, lawmakers, advocacy groups, and the pharmaceutical industry’s production of generic insulin versions, drug companies were encouraged to cut the cost of insulin for everyone.

“Lower costs will enable facilities to better care for their diabetic patients, which is a significant improvement for the health and well-being of our community,” says Melanie Williams, UnitedRx’s National Sales Representative. “Our patients have long had to pick between filling their medications and buying groceries. In the past, some people had to travel abroad to receive their medications. They are now currently more affordable in the United States than in Canada.”

The pharmacy benefit manager (PBM) landscape will also be impacted as insulin prices fall from $300 to $30 per vial. The Affordable Insulin Now Act requires that the copay for insulin be no more than $35, which will have an influence on PBMs and their brand-name requirements.

UnitedRx remains committed to providing quality long-term care pharmacy services and staying at the forefront of industry developments. As insulin prices continue to decrease, patients can expect to see an improvement in overall diabetic care and reduced healthcare costs.

At UnitedRx, we provide a hometown pharmacy experience to over 350 clients around the country. Contact us to learn more about how our treatment approach can satisfy your long-term care facility’s pharmacy needs.

About UnitedRx

UnitedRx is one of the largest, full-service, independent long-term care pharmacies headquartered in Illinois. Developed in 2008, UnitedRx has grown to over 350 facilities consisting of skilled nursing facilities, assisted living communities, youth homes, intermediate care facilities (ICF-DD), and hospice care. UnitedRx serves over 36,000 beds across 20 states with pharmacy locations in Illinois, Pennsylvania, Kansas, Nevada, and Tennessee, while employing over 350 people with an average of seven years of experience in the pharmaceutical industry. UnitedRx is committed to performing outstanding customer service to form meaningful and long-lasting relationships to produce positive results with facilities they partner with. For more information, visit https://www.unitedrx.net.

Share article on social media or email:

MedShift Completes $108 Million Capital Raise to Continue Innovation and Fuel Growth


News Image

The compilation facility solidi�es MedShift’s industry value and propels advancements across the companies three primary technologies; Specialty Device Subscription, Connected Medical Device (IoT), and the Velocity Technology Suite (Enterprise Software as a Service).

MedShift, a leading medical technology company, announced today it has completed a $108 million capital raise from Turning Rock Partners, Micota Capital, and OY6 Capital. The compilation facility solidifies MedShift’s industry value and propels advancements across the company’s three primary technologies: Specialty Device Subscription, Connected Medical Device (IoT), and the Velocity Technology Suite (Enterprise Software as a Service).

“The continued validation of MedShift’s holistic market offerings is very exciting to witness,” stated Brian Phillips, Executive Chairman and Co-Founder of MedShift. “Continued profitable growth was a catalyst to securing this raise, and the entire team executed flawlessly through wildly shifting market conditions to successfully complete the transaction. I look forward to the accelerated delivery of cutting-edge solutions to industry and practitioner partners this facility will support.”

MedShift has been at the forefront of developing technology solutions that serve a broad range of medical device manufacturers and practitioners across the Dermatology, Gynecology, Plastic Surgery, and MedSpa market. The company’s value proposition is unique in that it combines its expertise in designing, deploying, and maintaining innovative technology solutions for medical device manufacturers, with a range of complementary products and services.

“We are excited about the future of MedShift and the impact we can make on the healthcare industry,” said Joe Gasque, Chief Executive Officer of MedShift. “With MedShift, we aim to enrich aesthetic medical device manufacturers with high-quality, high-performing solutions that have the power to transform their business operations and help them achieve their goals. This additional funding will allow us to work towards fulfilling a significant unmet need.”

About MedShift

MedShift, a medical technology company founded in 2015 and headquartered in Charlotte, NC, is an emerging leader in the healthcare industry. MedShift is one of the largest and fastest growing solution providers to the aesthetic industry and is differentiated by its technology and software as a service focus. The company brings opportunities to drive growth and scale to medical device manufacturers as well as individual medical providers across various markets, including Dermatology, Gynecology, Plastic Surgery, and MedSpa. MedShift’s business is centered around three technology divisions, Specialty Device Subscription, Connected Medical Device (IoT), and the Velocity Technology Suite (Enterprise Software as a Service), and a range of complementary products and services that streamline the complex supply-and-demand landscape of device consumables and injectables. MedShift’s mission is to drive business transformation and power sales through the use of modern technology. The company currently has partnered with 25 aesthetic manufacturers and distributors, a portfolio of 80+ devices and over 2,000 active medical providers.

Share article on social media or email:

superbad inc. and BlazeToGo Delivery Announce Partnership to Expand into the Colorado Cannabis Market Continuing the Brand’s Nationwide Growth


superbad inc. high quality cannabis product line

Carlos Dew, Founder & CEO of superbad inc., said, “We are thrilled to expand our offerings to Colorado and provide a full suite of services and technology surrounding our launch.”

superbad inc. and BlazeToGo Delivery are proud to announce their partnership to bring high-quality cannabis products and services to the Colorado market. Building a platform for change both companies are Black-owned leaders in the cannabis space who are committed to providing top-tier products, services to their customers and their culture. With this partnership superbad inc. and BlazeToGo Delivery which is leading Colorado’s social equity efforts look to uplift each other as their companies continue to expand throughout the nation.

superbad inc., already a major vertically integrated player in California, Nevada, Oklahoma, and Michigan, is expanding to its fifth state with the addition of Colorado. Their products, including superbad inc. prerolls and house flower prepacks, will be available in stores and for delivery this April 2023.

Carlos Dew, Founder & CEO of superbad inc., said, “We are thrilled to expand our offerings to Colorado and provide a full suite of services and technology surrounding our launch.”

superbad inc. is committed to providing a wide range of products and services to their customers. From cultivation to consumption to culture, superbad inc. is committed to providing high-quality services to their customers from seed to smoke. With every interaction customers can earn points for special rewards within the superbad inc. retail outlets across the nation. In addition to products, superbad is bringing their worldwide platform for change that lives at the intersection of cannabis and social rights which aims to uplift the surrounding communities and partner with like-minded businesses that are pushing the industry forward.

BlazeToGo Delivery is leading Colorado’s social equity efforts and is proud to partner with superbad inc. to provide delivery services for their products. superbad inc. accessories, including lighters and rolling trays, and apparel, including hoodies, T-shirts, and crew necks, will also be available at select dispensaries.

“We are excited to partner with superbad inc. to bring their products and services to the Colorado market,” said Blaze Bradford, Owner & CEO of BlazeToGo Delivery. “We are committed to social equity efforts and providing our customers with the best products and services possible.”

superbad inc. and BlazeToGo Delivery invite customers to experience their products and services in retail stores or through delivery. For more information or inquiries, please visit the superbad inc. website http://www.superbadinc.com or follow on Instagram @superbad.inc. For more information on BlazeToGo Delivery visit blazetogo.com.

#superbadinc

#howbadareyou

#whatsyoursuperpower

#supercoloradolifestyle

#supermilehigh

#boulderbad

Share article on social media or email:



Northeast Delta HSA’s 2023 Youth Summit to Empower, Educate, And Elevate Carroll High Students


Northeast Delta HSA’s 2023 Youth Summit to Empower, Educate, And Elevate Carroll High Students

Northeast Delta HSA’s 2023 Youth Summit to Empower, Educate, And Elevate Carroll High Students

“We will continue to create a positive regional child, young adult, and family ecosystem that will further address the mental health, academic, social, and physical health needs of children and young adults much earlier than ever before,” Dr. Sizer said.

Northeast Delta Human Services Authority (NEDHSA) is set to host a Youth Summit at Carroll High School on May 5, 2023, from 9 a.m. – 11:30 a.m. NEDHSA’s Youth Summit is part of its mitigation efforts to combat teen suicide, underage drinking, mental illness, health and wellness challenges, low academic achievement, and more.

The theme for the Youth Summit is “Becoming the G.O.A.T. (Greatest of All Time),” which will focus on the impact youth can make in the community and help them understand the power within themselves. This event also aims to raise awareness of underage drinking and help youth recognize their power to make positive change.

NEDHSA Executive Director Dr. Monteic A. Sizer said, “We are committed to creating and providing the resources and innovations needed to help our region’s youth and young adults become more resilient, overcome adverse childhood trauma, and succeed academically.”

“We will continue to create a positive regional child, young adult, and family ecosystem that will further address the mental health, academic, social, and physical health needs of children and young adults much earlier than ever before,” Dr. Sizer said. “We also know that there is a direct correlation between childhood trauma and negative health outcomes for children and young adults. This is why we continue to do this innovative work.”

As part of NEDHSA’s continued effort to build a unified community where individuals thrive and reach their full human potential, targeting adolescents plays a crucial role. The key message is to raise awareness and reduce the incidence of underage drinking and other data-driven priorities in northeast Louisiana. This event will show adolescents that they are top priority and that NEDHSA is dedicated to reducing underage access to alcohol and underage drinking.

The Youth Summit will feature keynote speaker Louisiana-based Gospel Hip-Hop/ R&B artist Al “big AL” Cherry, a family man, motivational speaker, and preacher. There will also be local influencers and motivational speakers to share transformational words of encouragement and empowerment, such as the 2023 Miss University of Louisiana Monroe Leslie Hobgood and entrepreneur Mashi Epting.

The event will also feature JiggAerobics. JiggAerobics will be led by LaDonte Lotts, better known as “Mr. Get Right.” Lotts founded JiggAerobics as a dance-based fitness program that fuses “jigging,” an energetic Louisiana dance style, with Lotts’ dance moves and numerous plyometric exercises.

Dr. Sizer added: ” We know children and young adults are looking for authenticity and a place to belong. They are looking for genuine connections to be able to express their hopes, fears, and dreams. Therefore, we plan to further create lifesaving opportunities that are consistent with our various treatment and prevention and wellness innovations so that our region’s children and young adults can live and thrive.”

Share article on social media or email: